MIRM
NASDAQ · Biotechnology
Mirum Pharmaceuticals Inc
$107.16
+4.23 (+4.11%)
Performance
1D
—
1W
—
1M
—
3M
+6.58%
6M
+53.72%
1Y
+142.06%
YTD
+37.26%
Open$103.93
Previous Close$102.93
Day High$109.60
Day Low$103.76
52W High$112.00
52W Low$40.00
Volume—
Avg Volume964.3K
Market Cap6.21B
P/E Ratio—
EPS$-0.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$87.61
Above
SMA 200
$68.12
Above
RSI (14)
56.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
-37.7% upside
Current
$107.16
$107.16
Target
$66.73
$66.73
$36.90
$66.73 avg
$76.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 601.92M | 318.26M | 354.29M |
| Net Income | -26,974,451 | -12,836,147 | 95.30M |
| Profit Margin | -4.5% | -4.3% | 26.9% |
| EBITDA | 5.17M | 2.60M | 155.69M |
| Free Cash Flow | — | — | 58.63M |
| Rev Growth | +89.1% | +89.1% | +17.5% |
| Debt/Equity | 0.98 | 0.98 | 0.71 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |